"These targeted reforms are an important first step that will empower consumers, plans, providers and pharmacies to make informed, cost-effective and clinically appropriate decisions, ultimately driving down prescription drug costs for patients. I thank Senator Wyden and all members of the Committee for their partnership and contributions to this legislation, and look forward to incorporating additional policies to generate the broad bipartisan support that will lead to enactment."